Details of the Drug

General Information of Drug (ID: DM2E50J)

Drug Name

BI-638683

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01195688) Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects. U.S. National Institutes of Health.